Cumulative survival (%) of OBP-301-injected patients
Kaplan-Meier curve of surviving patients. (A) Overall survival (OS) of all patients who completed the treatment protocols. The overall median OS was 26.00 weeks. (B) Survival curve according to groups. The median OS from the Kaplan-Meier analysis was 40.86 weeks (cohort 2), 12.86 weeks (cohort 4), and 23.00 weeks (cohort 5). (C) Survival curve according to the local response. SD, 102.6 weeks; PD, 14.1 weeks.